18h
Acute respiratory distress syndrome patients improve with experimental monoclonal antibody treatment
Doctors have few options for patients who develop a life-threatening lung condition called acute respiratory distress syndrome, or ARDS. A frequent cause of death during the COVID-19 pandemic, ARDS ...
Doctors have few options for patients who develop a life-threatening lung condition called acute respiratory distress ...
A new study frames TREM-1 as an upstream innate immune amplifier, mapping out a new therapeutic target for sepsis, arthritis, and neurodegeneration.
For decades, scientists have thought they understood the biochemical machinery that causes asthma-inflammation in the lungs that constricts airways and makes it hard to breathe. Molecules called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results